Neurologic and Cognitive Outcomes in Sickle Cell Disease from Infancy through Adolescence

Area of Science:

• Pediatric Neurology
• Hematology
• Neuroscience

Background:

• Sickle cell disease (SCD) poses significant risks for neurologic and cognitive deficits in children.
• Early childhood is a critical period for the onset of these complications.
• Current SCD management prioritizes primary prevention strategies.

Purpose of the Study:

• To review the prevalence of neurologic and cognitive complications in pediatric SCD.
• To elucidate the pathophysiology underlying these SCD-related brain issues.
• To summarize existing and novel interventions for prevention and treatment.

Main Methods:

• Literature review of studies on SCD and its neurologic/cognitive impact.
• Analysis of current treatment guidelines and emerging therapeutic approaches.
• Synthesis of data on prevalence, pathophysiology, and interventions.

Main Results:

• Children with SCD are susceptible to early-onset neurologic and cognitive problems.
• Hydroxyurea and chronic transfusions are key preventive measures for specific complications.
• A comprehensive understanding of pathophysiology informs intervention strategies.

Conclusions:

• Neurologic and cognitive complications are a major concern in pediatric SCD.
• Proactive management and tailored interventions are crucial for improving outcomes.
• Further research into pathophysiology and treatment is warranted to mitigate long-term effects.